You may all be familiar with our next play and we could all possibly see some resembling results.
With a recently increasing price per share, AXXE could still very well be towards the bottom of its upswing. This could be JUST THE BEGINNING!
AXXE (Axxess Pharma, Inc.)
Axxess Pharma, Inc. is a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription medical products in niche markets. Although they serve the General Practice market, Axxess Pharma, Inc. also distributes products that target Dermatology, Rheumatology, Gynecology, Urology and Nephrology markets.
And also just to refresh your memory, AXXE’s wholly-owned subsidiary, AllStar Health Brands Inc. distributes Axxess Pharma's full line of TapouT products throughout the United States.
Management anticipates distribution into thousands of retail stores by the middle of 2015.
Just last week AXXE through it's AllStar Health Brands subsidiary, announced that it had received approval from a major Canadian distributor to sell TapouT Muscle Spray and TapouT Pain relief Towelettes to over 2,000 independent pharmacies across Canada.
According to the Company, this represents approximately 10% of all Canadian pharmacies.
This falls in line with the new trends for 2015 as Axxess, being a healthy lifestyle supplement provider, has also identified the overall opportunity to expand beyond body maintenance stores or active lifestyle outlets and into additional markets that address the growing need for alternative remedies.
Since the end of 2014, AXXE has been on a rally path. Over the last 2 weeks, the stock has moved up by more than 30% after hitting new daily highs. This not only marks a significant move for 2015 but it also signifies the new market opportunities that healthcare companies are looking for in the year ahead.
On Wednesday, January 21st AXXE returned from the national ECRM event with scheduled follow-up meetings with big box retail chain stores and specialty stores.
You can read the whole story here: http://finance.yahoo.com/news/axxess-pharma-returns-national-ecrm-163740939.html
AXXE prides themselves in providing cost-effective therapeutic options for patients, especially in underserved disease segments.
Over the Counter and prescription products will be introduced in Canada and other countries. Prescription products will consist of specialized medicines with few competitors.
At its core, AXXE is a specialty pharmaceutical and nutritional supplements company that offers select medicines, nutritional supplements, and over the counter remedies in the Americas.
The company, through its subsidiary, Axxess Pharma Canada Inc., offers prescription and non-prescription products to improve health-related conditions, including various forms of iron deficiency, bone loss, rheumatoid arthritis, migraine headaches, urinary tract infections, infant cradle cap, joint pain, and more.
Its prescription products include Britical, Vivol, Soropon, Somnol, Kemsol, Lactrose, Niaxx, Urasal, Monurol, Axspaz, and Hydraxx; and non-prescription products include Hydraxx 2%, Hydraxx Serum, Potassium Chloride liquid, Hydraxx Serum Eyes, Calcium Citrate with VitaminD, Kemsol for Scleroderma, Soropon Shampoo, and Hydraxx 1%.
The company was founded in 1997 and is headquartered in Toronto, Canada.
BUSINESS SUMMARY
(AXXE – Axxes Pharma, Inc.)
Axxess Pharma, Inc. is a Nevada Corporation operating through its wholly owned Canadian subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain -- to optimal health management through improved nutritional supplements.
To learn more about our new products TapouT Extreme Muscle Growth and TapouT Muscle Recovery, visit http://www.tapoutmusclerecovery.com.
Axxess Pharma: a focused healthcare company dedicated to providing a wide range of products to improve the lives of patients and consumers worldwide.
They believe action defines leadership.
MARKET OUTLOOK
The over-the-counter (OTC) pharmaceutical market includes non- prescription medicines that are sold directly to consumers through pharmacies, drugstores, convenience stores and grocery stores. Most countries follow the “two-class system” for the classification of medicines as prescription (Rx) or non-prescription (OTC). The OTC pharmaceutical market may be segmented into multiple categories such as analgesics, cold, cough and allergy, digestive remedies, traditional medicines, and vitamins and minerals.
A new report by visiongain predicts that the world market for over-the-counter (OTC) medicines will reach around $80 billion for 2014 (we’ll see those numbers soon). That revenue forecast appears in World OTC Pharmaceutical Market 2012-2022.
INVESTOR HIGHLIGHTS
AXXE has seen spurts of positive action throughout the last few months; a combination of all this new informative material could send this thing up even FURTHER!
AXXE has released multiple important press releases that warrants investor’s attention, (in my unlicensed, amateur opinion).
AXXE appears to have the right combination for success in one the largest global industries.
AXXE is a small-cap company with the potential to show big swings.
AXXE has an experienced team that is looking out for the companies/shareholders best interests.
Take your time and do your own analyzing and research now. This could be an opportunity for something special.
By now you all know the drill but sometimes some important details get forgotten, so remember, never risk more than you could afford to lose and always book a profit when you can.
